{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T05:40:19Z","timestamp":1775626819417,"version":"3.50.1"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","award":["982565"],"award-info":[{"award-number":["982565"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.intimp.2020.106471","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T12:38:50Z","timestamp":1587040730000},"page":"106471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Tumor associated macrophages in the molecular pathogenesis of ovarian cancer"],"prefix":"10.1016","volume":"84","author":[{"given":"Yousef","family":"Yousefzadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahin","family":"Hallaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Baghi Moornani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Asghary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gholamreza","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Hojjat-Farsangi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghasem","family":"Ghalamfarsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad","family":"Jadidi-Niaragh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2020.106471_b0005","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1074\/mcp.RA117.000400","article-title":"Proteotranscriptomics reveal signaling networks in the ovarian cancer microenvironment","volume":"17","author":"Worzfeld","year":"2018","journal-title":"Mol. Cell. Proteomics"},{"issue":"1","key":"10.1016\/j.intimp.2020.106471_b0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10555-013-9456-2","article-title":"Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition","volume":"33","author":"Thibault","year":"2014","journal-title":"Cancer Metastasis Rev."},{"issue":"2","key":"10.1016\/j.intimp.2020.106471_b0015","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ygyno.2010.02.012","article-title":"The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment","volume":"117","author":"Despierre","year":"2010","journal-title":"Gynecol. Oncol."},{"issue":"16","key":"10.1016\/j.intimp.2020.106471_b0020","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","article-title":"Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome","volume":"14","author":"Tothill","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2020.106471_b0025","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ygyno.2015.02.003","article-title":"The PI3K\/AKT\/mTOR pathway as a therapeutic target in ovarian cancer","volume":"137","author":"Mabuchi","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.intimp.2020.106471_b0030","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/intimm\/dxw020","article-title":"Immune checkpoint inhibition in ovarian cancer","volume":"28","author":"Hamanishi","year":"2016","journal-title":"Int. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106471_b0035","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ygyno.2010.01.019","article-title":"Ovarian cancer creates a suppressive microenvironment to escape immune elimination","volume":"117","author":"Yigit","year":"2010","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.intimp.2020.106471_b0040","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106471_b0045","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nri2922","article-title":"Immunometabolism: an emerging frontier","volume":"11","author":"Mathis","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2020.106471_b0050","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.2012.01158.x","article-title":"Metabolism and autophagy in the immune system: immunometabolism comes of age","volume":"249","author":"Rathmell","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2020.106471_b0055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fonc.2014.00107","article-title":"Targeting T cell immunometabolism for cancer immunotherapy; understanding the impact of the tumor microenvironment","volume":"4","author":"Mockler","year":"2014","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2020.106471_b0060","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10555-006-9001-7","article-title":"Role of tumor-associated macrophages in tumor progression and invasion","volume":"25","author":"Mantovani","year":"2006","journal-title":"Cancer Metastasis Rev."},{"issue":"1","key":"10.1016\/j.intimp.2020.106471_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cmi.2014.83","article-title":"The origin and function of tumor-associated macrophages","volume":"12","author":"Liu","year":"2015","journal-title":"Cell. Mol. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2020.106471_b0070","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even warburg did not anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2020.106471_b0075","doi-asserted-by":"crossref","first-page":"116952","DOI":"10.1016\/j.lfs.2019.116952","article-title":"Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells","author":"Hajizadeh","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2020.106471_b0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2017.12.019","article-title":"Cancer, obesity and immunometabolism\u2013Connecting the dots","volume":"417","author":"Dyck","year":"2018","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.intimp.2020.106471_b0085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cell.2009.11.027","article-title":"Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis","volume":"140","author":"Nomura","year":"2010","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.intimp.2020.106471_b0090","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","article-title":"Understanding the intersections between metabolism and cancer biology","volume":"168","author":"Vander Heiden","year":"2017","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.intimp.2020.106471_b0095","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.immuni.2015.09.001","article-title":"Metabolic reprogramming of immune cells in cancer progression","volume":"43","author":"Biswas","year":"2015","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.intimp.2020.106471_b0100","doi-asserted-by":"crossref","first-page":"e1600200","DOI":"10.1126\/sciadv.1600200","article-title":"Fundamentals of cancer metabolism","volume":"2","author":"DeBerardinis","year":"2016","journal-title":"Sci. Adv."},{"issue":"10","key":"10.1016\/j.intimp.2020.106471_b0105","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1158\/2159-8290.CD-15-0507","article-title":"MYC, metabolism, and cancer","volume":"5","author":"Stine","year":"2015","journal-title":"Cancer Discovery"},{"issue":"7","key":"10.1016\/j.intimp.2020.106471_b0110","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrm4007","article-title":"p53 in survival, death and metabolic health: a lifeguard with a licence to kill","volume":"16","author":"Kruiswijk","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7519","key":"10.1016\/j.intimp.2020.106471_b0115","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.intimp.2020.106471_b0120","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1089\/ars.2007.1825","article-title":"LPS induces hypoxia-inducible factor 1 activation in macrophage-differentiated cells in a reactive oxygen species\u2013dependent manner","volume":"10","author":"Nishi","year":"2008","journal-title":"Antioxid. Redox Signal."},{"issue":"6155","key":"10.1016\/j.intimp.2020.106471_b0125","doi-asserted-by":"crossref","first-page":"1242454","DOI":"10.1126\/science.1242454","article-title":"Fueling immunity: insights into metabolism and lymphocyte function","volume":"342","author":"Pearce","year":"2013","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.intimp.2020.106471_b0130","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ni.1937","article-title":"Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm","volume":"11","author":"Biswas","year":"2010","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2020.106471_b0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2020.106471_b0140","series-title":"Seminars in Immunopathology","first-page":"585","article-title":"Tumor-associated macrophages: functional diversity, clinical significance, and open questions","author":"Biswas","year":"2013"},{"issue":"6","key":"10.1016\/j.intimp.2020.106471_b0145","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.intimp.2020.106471_b0150","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ccell.2014.09.006","article-title":"Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells","volume":"26","author":"Ruffell","year":"2014","journal-title":"Cancer Cell"},{"issue":"6186","key":"10.1016\/j.intimp.2020.106471_b0155","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.1252510","article-title":"The cellular and molecular origin of tumor-associated macrophages","volume":"344","author":"Franklin","year":"2014","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.intimp.2020.106471_b0160","doi-asserted-by":"crossref","first-page":"605","DOI":"10.4049\/jimmunol.0901698","article-title":"Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation","volume":"185","author":"Rodr\u00edguez-Prados","year":"2010","journal-title":"J. Immunol."},{"issue":"7444","key":"10.1016\/j.intimp.2020.106471_b0165","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nature11986","article-title":"Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1","volume":"496","author":"Tannahill","year":"2013","journal-title":"Nature"},{"issue":"6204","key":"10.1016\/j.intimp.2020.106471_b0170","doi-asserted-by":"crossref","first-page":"1250684","DOI":"10.1126\/science.1250684","article-title":"mTOR-and HIF-1\u03b1\u2013mediated aerobic glycolysis as metabolic basis for trained immunity","volume":"345","author":"Cheng","year":"2014","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.intimp.2020.106471_b0175","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.4049\/jimmunol.0902584","article-title":"Lactic acid and acidification inhibit TNF secretion and glycolysis of human monocytes","volume":"184","author":"Dietl","year":"2010","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2020.106471_b0180","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10875-012-9847-0","article-title":"Cancer-related inflammation","volume":"33","author":"Candido","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.intimp.2020.106471_b0185","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0092-8674(03)00311-8","article-title":"HIF-1 is essential for myeloid cell-mediated inflammation","volume":"113","author":"Mackman","year":"2003","journal-title":"Cell"},{"issue":"7203","key":"10.1016\/j.intimp.2020.106471_b0190","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"issue":"7508","key":"10.1016\/j.intimp.2020.106471_b0195","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nature13312","article-title":"Metabolism of stromal and immune cells in health and disease","volume":"511","author":"Ghesqui\u00e8re","year":"2014","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.intimp.2020.106471_b0200","doi-asserted-by":"crossref","first-page":"8429","DOI":"10.1158\/0008-5472.CAN-07-1684","article-title":"Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2","volume":"67","author":"Lewis","year":"2007","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2020.106471_b0205","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2009.06.018","article-title":"CD4+ T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages","volume":"16","author":"DeNardo","year":"2009","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.intimp.2020.106471_b0210","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cmet.2014.12.005","article-title":"Pyruvate kinase M2 regulates Hif-1\u03b1 activity and IL-1\u03b2 induction and is a critical determinant of the warburg effect in LPS-activated macrophages","volume":"21","author":"Palsson-McDermott","year":"2015","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.intimp.2020.106471_b0215","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.it.2011.03.007","article-title":"Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype","volume":"32","author":"Cairo","year":"2011","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2020.106471_b0220","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/eji.200939889","article-title":"Differential regulation of iron homeostasis during human macrophage polarized activation","volume":"40","author":"Recalcati","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106471_b0225","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.imbio.2014.09.011","article-title":"Macrophage iron homeostasis and polarization in the context of cancer","volume":"220","author":"Jung","year":"2015","journal-title":"Immunobiology"},{"issue":"51","key":"10.1016\/j.intimp.2020.106471_b0230","doi-asserted-by":"crossref","first-page":"39976","DOI":"10.1074\/jbc.M110.182915","article-title":"A mouse macrophage lipidome","volume":"285","author":"Dennis","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2020.106471_b0235","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev-pathol-011110-130138","article-title":"Alternative macrophage activation and metabolism","volume":"6","author":"Odegaard","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.intimp.2020.106471_b0240","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3389\/fimmu.2014.00532","article-title":"Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages","volume":"5","author":"Rath","year":"2014","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2020.106471_b0245","first-page":"1100","article-title":"Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity","volume":"61","author":"Chang","year":"2001","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.intimp.2020.106471_b0250","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.immuni.2015.02.005","article-title":"Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization","volume":"42","author":"Jha","year":"2015","journal-title":"Immunity"},{"issue":"14","key":"10.1016\/j.intimp.2020.106471_b0255","first-page":"3362","article-title":"Sensitivity of tumoricidal function in macrophages from different anatomical sites of cancer patients to modulation of arachidonic acid metabolism","volume":"53","author":"Braun","year":"1993","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.intimp.2020.106471_b0260","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/onc.2014.85","article-title":"Increased metabolites of 5-lipoxygenase from hypoxic ovarian cancer cells promote tumor-associated macrophage infiltration","volume":"34","author":"Wen","year":"2015","journal-title":"Oncogene"},{"issue":"23","key":"10.1016\/j.intimp.2020.106471_b0265","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1158\/0008-5472.CAN-15-0706","article-title":"Obesity contributes to ovarian cancer metastatic success through increased lipogenesis, enhanced vascularity, and decreased infiltration of M1 macrophages","volume":"75","author":"Liu","year":"2015","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.intimp.2020.106471_b0270","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00262-010-0836-y","article-title":"Thrombin facilitates invasion of ovarian cancer along peritoneum by inducing monocyte differentiation toward tumor-associated macrophage-like cells","volume":"59","author":"Zhang","year":"2010","journal-title":"Cancer Immunol. Immunother."},{"issue":"6","key":"10.1016\/j.intimp.2020.106471_b0275","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.3892\/or.2014.3127","article-title":"CDK2 and CDK4 play important roles in promoting the proliferation of SKOV3 ovarian carcinoma cells induced by tumor-associated macrophages","volume":"31","author":"Yang","year":"2014","journal-title":"Oncol. Rep."},{"issue":"9","key":"10.1016\/j.intimp.2020.106471_b0280","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1172\/JCI99169","article-title":"Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors","volume":"128","author":"Weiss","year":"2018","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.intimp.2020.106471_b0285","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1073\/pnas.1803999116","article-title":"Suppression of chemotherapy-induced cytokine\/lipid mediator surge and ovarian cancer by a dual COX-2\/sEH inhibitor","volume":"116","author":"Gartung","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2020.106471_b0290","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.prp.2018.12.017","article-title":"Clinical significance of M2 macrophages expressing heme oxygenase-1 in malignant transformation of ovarian endometrioma","volume":"215","author":"Yamada","year":"2019","journal-title":"Pathol.-Res. Pract."},{"issue":"5","key":"10.1016\/j.intimp.2020.106471_b0295","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1440-1827.2009.02369.x","article-title":"Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors","volume":"59","author":"Kawamura","year":"2009","journal-title":"Pathol. Int."},{"issue":"1","key":"10.1016\/j.intimp.2020.106471_b0300","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1479-5876-4-30","article-title":"Monocyte\/macrophage and T-cell infiltrates in peritoneum of patients with ovarian cancer or benign pelvic disease","volume":"4","author":"Wang","year":"2006","journal-title":"J. Translat. Med."},{"issue":"2","key":"10.1016\/j.intimp.2020.106471_b0305","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygyno.2008.01.010","article-title":"Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer","volume":"109","author":"Shah","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2020.106471_b0310","doi-asserted-by":"crossref","first-page":"259","DOI":"10.7785\/tcrt.2012.500312","article-title":"Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer","volume":"12","author":"Lan","year":"2013","journal-title":"Technol. Cancer Res. Treat."},{"issue":"6","key":"10.1016\/j.intimp.2020.106471_b0315","doi-asserted-by":"crossref","first-page":"e38541","DOI":"10.1371\/journal.pone.0038541","article-title":"BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosis","volume":"7","author":"Le Page","year":"2012","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.intimp.2020.106471_b0320","first-page":"3407","article-title":"Toxicity, immunogenicity, and induction of E75-specific tumor-lytic CTLs by HER-2 peptide E75 (369\u2013377) combined with granulocyte macrophage colony-stimulating factor in HLA-A2+ patients with metastatic breast and ovarian cancer","volume":"8","author":"Murray","year":"2002","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2020.106471_b0325","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1593\/neo.81150","article-title":"Enhanced ovarian cancer tumorigenesis and metastasis by the macrophage colony-stimulating factor","volume":"11","author":"Toy","year":"2009","journal-title":"Neoplasia"},{"issue":"20","key":"10.1016\/j.intimp.2020.106471_b0330","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1200\/JCO.2004.03.091","article-title":"Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15\u20133, CA 72\u20134, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions","volume":"22","author":"Skates","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.intimp.2020.106471_b0335","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000349892","article-title":"Prognostic significance of serum soluble CD163 level in patients with epithelial ovarian cancer","volume":"75","author":"No","year":"2013","journal-title":"Gynecol. Obstet. Invest."},{"issue":"12","key":"10.1016\/j.intimp.2020.106471_b0340","doi-asserted-by":"crossref","first-page":"e79769","DOI":"10.1371\/journal.pone.0079769","article-title":"High MUC2 expression in ovarian cancer is inversely associated with the M1\/M2 ratio of tumor-associated macrophages and patient survival time","volume":"8","author":"He","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.intimp.2020.106471_b0345","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1757-2215-7-19","article-title":"A high M1\/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients","volume":"7","author":"Zhang","year":"2014","journal-title":"J. Ovarian Res."},{"issue":"18","key":"10.1016\/j.intimp.2020.106471_b0350","doi-asserted-by":"crossref","first-page":"8900","DOI":"10.1158\/0008-5472.CAN-07-1866","article-title":"Relationship between B7\u2013H4, regulatory T cells, and patient outcome in human ovarian carcinoma","volume":"67","author":"Kryczek","year":"2007","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.intimp.2020.106471_b0355","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1182\/blood-2007-02-072587","article-title":"Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells","volume":"110","author":"Duluc","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.intimp.2020.106471_b0360","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ijc.28335","article-title":"Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: Correlation of CD163 expression, cytokine levels and early relapse","volume":"134","author":"Reinartz","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.intimp.2020.106471_b0365","first-page":"375","article-title":"Proinflammatory and immunosuppressive serum, ascites and cyst fluid cytokines in patients with early and advanced ovarian cancer and benign ovarian tumors","volume":"31","author":"Nowak","year":"2010","journal-title":"Neuro Endocrinol. Lett."},{"issue":"8","key":"10.1016\/j.intimp.2020.106471_b0370","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.4049\/jimmunol.176.8.5023","article-title":"Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype","volume":"176","author":"Hagemann","year":"2006","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2020.106471_b0375","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.4049\/jimmunol.1203194","article-title":"Macrophage scavenger receptor a promotes tumor progression in murine models of ovarian and pancreatic cancer","volume":"190","author":"Neyen","year":"2013","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106471_b0380","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.4049\/jimmunol.175.2.1197","article-title":"Macrophages induce invasiveness of epithelial cancer cells via NF-\u03baB and JNK","volume":"175","author":"Hagemann","year":"2005","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2020.106471_b0385","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1158\/1535-7163.MCT-07-0118","article-title":"Ovarian cancer cell\u2013derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis","volume":"6","author":"Hagemann","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.intimp.2020.106471_b0390","series-title":"Ovarian Cancer","first-page":"121","article-title":"Bioactive interleukin-6 levels in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer","author":"Gastl","year":"2000"},{"issue":"8","key":"10.1016\/j.intimp.2020.106471_b0395","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1158\/0008-5472.CAN-12-3542","article-title":"Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironment","volume":"73","author":"Dijkgraaf","year":"2013","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.intimp.2020.106471_b0400","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1158\/0008-5472.CAN-05-3948","article-title":"TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer","volume":"66","author":"Kelly","year":"2006","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2020.106471_b0405","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4161\/cc.8.1.7533","article-title":"Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance","volume":"8","author":"Alvero","year":"2009","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.intimp.2020.106471_b0410","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1600-0897.2011.01068.x","article-title":"Distinct subpopulations of epithelial ovarian cancer cells can differentially induce macrophages and T regulatory cells toward a pro-tumor phenotype","volume":"67","author":"Alvero","year":"2012","journal-title":"Am. J. Reprod. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2020.106471_b0415","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1111\/j.1349-7006.2010.01652.x","article-title":"Involvement of M2-polarized macrophages in the ascites from advanced epithelial ovarian carcinoma in tumor progression via Stat3 activation","volume":"101","author":"Takaishi","year":"2010","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.intimp.2020.106471_b0420","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40425-016-0154-9","article-title":"Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages\u2013a self-amplifying, CD39-and CD73-dependent mechanism for tumor immune escape","volume":"4","author":"del Barrio","year":"2016","journal-title":"J. ImmunoTher. Cancer"},{"issue":"28","key":"10.1016\/j.intimp.2020.106471_b0425","doi-asserted-by":"crossref","first-page":"43076","DOI":"10.18632\/oncotarget.9246","article-title":"Epithelial ovarian cancer-secreted exosomal miR-222-3p induces polarization of tumor-associated macrophages","volume":"7","author":"Ying","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.intimp.2020.106471_b0430","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3892\/or.2017.5697","article-title":"Exosomes derived from hypoxic epithelial ovarian cancer deliver microRNA-940 to induce macrophage M2 polarization","volume":"38","author":"Chen","year":"2017","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2020.106471_b0435","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3892\/ijmm.2015.2230","article-title":"Ovarian cancer stem cells induce the M2 polarization of macrophages through the PPAR\u03b3 and NF-\u03baB pathways","volume":"36","author":"Deng","year":"2015","journal-title":"Int. J. Mol. Med."},{"issue":"34","key":"10.1016\/j.intimp.2020.106471_b0440","doi-asserted-by":"crossref","first-page":"E3562","DOI":"10.1073\/pnas.1403424111","article-title":"Murine CD27 (\u2212) V\u03b36 (+) \u03b3\u03b4 T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages","volume":"111","author":"Rei","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2020.106471_b0445","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.3892\/or.2016.5136","article-title":"Interaction between Treg cells and tumor-associated macrophages in the tumor microenvironment of epithelial ovarian cancer","volume":"36","author":"Zhu","year":"2016","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.intimp.2020.106471_b0450","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1158\/1078-0432.CCR-05-2254","article-title":"Defective antitumor function of monocyte-derived macrophages from epithelial ovarian cancer patients","volume":"12","author":"Gordon","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.intimp.2020.106471_b0455","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.intimp.2020.106471_b0460","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1084\/jem.20050930","article-title":"B7\u2013H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma","volume":"203","author":"Kryczek","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2020.106471_b0465","article-title":"Engagement of the mannose receptor by tumoral mucins activates an immune suppressive phenotype in human tumor-associated macrophages","volume":"2010","author":"Allavena","year":"2011","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.intimp.2020.106471_b0470","first-page":"75","article-title":"Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis","volume":"5","author":"Kzhyshkowska","year":"2014","journal-title":"Front. Physiol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106471_b0475","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1172\/JCI118815","article-title":"Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids","volume":"98","author":"McLaren","year":"1996","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.intimp.2020.106471_b0480","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/cas.12110","article-title":"Interaction of monocytes\/macrophages with ovarian cancer cells promotes angiogenesis in vitro","volume":"104","author":"Wang","year":"2013","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.intimp.2020.106471_b0485","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3892\/ol.2016.5428","article-title":"Differential distribution of tumor-associated macrophages and Treg\/Th17 cells in the progression of malignant and benign epithelial ovarian tumors","volume":"13","author":"Zhu","year":"2017","journal-title":"Oncol. Lett."},{"issue":"22","key":"10.1016\/j.intimp.2020.106471_b0490","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1158\/0008-5472.CAN-14-3373","article-title":"Macrophage blockade using CSF1R inhibitors reverses the vascular leakage underlying malignant ascites in late-stage epithelial ovarian cancer","volume":"75","author":"Moughon","year":"2015","journal-title":"Cancer Res."},{"issue":"15","key":"10.1016\/j.intimp.2020.106471_b0495","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/jnci\/94.15.1134","article-title":"Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice","volume":"94","author":"Huang","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.intimp.2020.106471_b0500","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0002-9440(10)64873-0","article-title":"Vascular endothelial growth factor-165 overexpression stimulates angiogenesis and induces cyst formation and macrophage infiltration in human ovarian cancer xenografts","volume":"160","author":"Duyndam","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"46","key":"10.1016\/j.intimp.2020.106471_b0505","doi-asserted-by":"crossref","first-page":"75339","DOI":"10.18632\/oncotarget.12180","article-title":"The transcriptional signature of human ovarian carcinoma macrophages is associated with extracellular matrix reorganization","volume":"7","author":"Finkernagel","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.intimp.2020.106471_b0510","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1158\/0008-5472.CAN-06-4375","article-title":"Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice","volume":"67","author":"Robinson-Smith","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2020.106471_b0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2019.05.029","article-title":"Alternatively activated macrophage-derived secretome stimulates ovarian cancer spheroid spreading through a JAK2\/STAT3 pathway","author":"Fogg","year":"2019","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.intimp.2020.106471_b0520","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1172\/JCI87252","article-title":"Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer","volume":"126","author":"Yin","year":"2016","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.intimp.2020.106471_b0525","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/mc.22750","article-title":"Pro-inflammatory M1 macrophage enhances metastatic potential of ovarian cancer cells through NF-\u03baB activation","volume":"57","author":"Cho","year":"2018","journal-title":"Mol. Carcinog."},{"issue":"59","key":"10.1016\/j.intimp.2020.106471_b0530","doi-asserted-by":"crossref","first-page":"99950","DOI":"10.18632\/oncotarget.21556","article-title":"The humanized anti-human AMHRII mAb 3C23K exerts an anti-tumor activity against human ovarian cancer through tumor-associated macrophages","volume":"8","author":"Bougherara","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2020.106471_b0535","doi-asserted-by":"crossref","first-page":"29588","DOI":"10.1038\/srep29588","article-title":"Onionin A inhibits ovarian cancer progression by suppressing cancer cell proliferation and the protumour function of macrophages","volume":"6","author":"Tsuboki","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2020.106471_b0540","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13046-019-1095-1","article-title":"Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype","volume":"38","author":"Zhu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.intimp.2020.106471_b0545","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s13277-013-0832-x","article-title":"Regulatory T cells in chronic lymphocytic leukemia: implication for immunotherapeutic interventions","volume":"34","author":"Jadidi-Niaragh","year":"2013","journal-title":"Tumor Biol."},{"issue":"3","key":"10.1016\/j.intimp.2020.106471_b0550","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s13277-013-0743-x","article-title":"The role of natural killer T cells in B cell malignancies","volume":"34","author":"Ghalamfarsa","year":"2013","journal-title":"Tumor Biol."},{"issue":"10","key":"10.1016\/j.intimp.2020.106471_b0555","doi-asserted-by":"crossref","first-page":"7339","DOI":"10.1007\/s13277-015-4004-z","article-title":"Myeloid-derived suppressor cells in B cell malignancies","volume":"36","author":"Yazdani","year":"2015","journal-title":"Tumor Biol."},{"issue":"10","key":"10.1016\/j.intimp.2020.106471_b0560","doi-asserted-by":"crossref","first-page":"7165","DOI":"10.1002\/jcp.26743","article-title":"Anti-angiogenic effects of CD73-specific siRNA-loaded nanoparticles in breast cancer-bearing mice","volume":"233","author":"Ghalamfarsa","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106471_b0565","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/14728222.2019.1559829","article-title":"CD73 as a potential opportunity for cancer immunotherapy","volume":"23","author":"Ghalamfarsa","year":"2019","journal-title":"Expert Opin. Therapeut. Targets"},{"key":"10.1016\/j.intimp.2020.106471_b0570","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.biopha.2018.09.177","article-title":"The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer","volume":"108","author":"Masjedi","year":"2018","journal-title":"Biomed. Pharmacother."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919329297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919329297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T19:20:35Z","timestamp":1754508035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576919329297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":114,"alternative-id":["S1567576919329297"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106471","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor associated macrophages in the molecular pathogenesis of ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106471"}}